CD79A and Alzheimer disease: Previous studies have analysed IgA antibody levels in the blood of AD patients and healthy age-matched controls, but the results are inconsistent with demonstrating either increased [15–18], unaltered [19, 20], or decreased [21] blood IgA levels in AD patients compared to healthy controls.